Cargando…

Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A

BACKGROUND: Animal studies have highlighted the role of vascular mineralocorticoid receptor during Cyclosporine A-induced nephrotoxicity. Mineralocorticoid receptor antagonists could improve kidney survival but are not commonly used during renal impairment and in association with several immunosuppr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertocchio, Jean-Philippe, Barbe, Coralie, Lavaud, Sylvie, Toupance, Olivier, Nazeyrollas, Pierre, Jaisser, Frederic, Rieu, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835088/ https://www.ncbi.nlm.nih.gov/pubmed/27088859 http://dx.doi.org/10.1371/journal.pone.0153635

Ejemplares similares

EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial
por: Girerd, Sophie, et al.
Publicado: (2018)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

The mineralocorticoid receptor antagonist eplerenone reduces renal interstitial fibrosis after long-term cyclosporine treatment in rat: antagonizing cyclosporine nephrotoxicity
por: Nielsen, Finn Thomsen, et al.
Publicado: (2013)

Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A
por: Niemczyk, Mariusz
Publicado: (2013)

The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice
por: Figueroa, Stefanny M., et al.
Publicado: (2023)

Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
por: Huh, Kyungmin, et al.
Publicado: (2013)

Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
por: Lin, Yi-Chang, et al.
Publicado: (2019)

Eplerenone ethanol solvate
por: Yang, Qian, et al.
Publicado: (2008)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
por: Mansell, Holly, et al.
Publicado: (2022)

The Non-Steroidal Mineralocorticoid Receptor Antagonist KBP-5074 Limits Albuminuria and has Improved Therapeutic Index Compared With Eplerenone in a Rat Model With Mineralocorticoid-Induced Renal Injury
por: Jaisser, Frédéric, et al.
Publicado: (2021)

Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients
por: Baek, Hyunjeong, et al.
Publicado: (2014)

Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients
por: Vuiblet, Vincent, et al.
Publicado: (2016)

Electrolytes Disturbance and Cyclosporine Blood Levels among Kidney Transplant Recipients
por: Einollahi, B., et al.
Publicado: (2012)

Effect of Eplerenone on Diastolic Function in Women Receiving Anthracycline-Based Chemotherapy for Breast Cancer
por: Davis, Margot K., et al.
Publicado: (2019)

Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient
por: Hasan, Ashfaq, et al.
Publicado: (2014)

Late presentation of toxoplasmosis in renal transplant recipients
por: Clissold, Rhian, et al.
Publicado: (2010)

Cyclosporine A Impairs Nucleotide Binding Oligomerization Domain (Nod1)-Mediated Innate Antibacterial Renal Defenses in Mice and Human Transplant Recipients
por: Tourneur, Emilie, et al.
Publicado: (2013)

Cyclosporine Effects on Pediatric Kidney Recipients
por: Hami, Maryam
Publicado: (2012)

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
por: Handisurya, Ammon, et al.
Publicado: (2016)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015)

Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Belatacept associated - cytomegalovirus retinitis in a kidney transplant recipient: a case report and review of the literature
por: Deliège, Pierre-Guillaume, et al.
Publicado: (2020)

Frequency and Risk Factors of Cyclosporine-Induced Neurotoxicity in Allogeneic Stem Cell Transplant Recipients
por: Danish, Asma, et al.
Publicado: (2021)

Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation
por: Li, Tai-feng, et al.
Publicado: (2019)

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
por: Lunde, Ingrid, et al.
Publicado: (2014)

Applying machine learning to the pharmacokinetic modeling of cyclosporine in adult renal transplant recipients: a multi-method comparison
por: Mao, Junjun, et al.
Publicado: (2022)

Alloimmune haemolysis in a renal transplant recipient receiving sirolimus
por: Hedley, Adam J., et al.
Publicado: (2008)

Eplerenone use in primary aldosteronism during pregnancy
por: Gunganah, Kirun, et al.
Publicado: (2015)

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

Comparison between swallowing and chewing of garlic on levels of serum lipids, cyclosporine, creatinine and lipid peroxidation in Renal Transplant Recipients
por: Jabbari, Abbas, et al.
Publicado: (2005)

Acute myopathy induced by colchicine in a cyclosporine-treated renal transplant recipient--a case report and review of the literature.
por: Lee, B. I., et al.
Publicado: (1997)

The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy
por: Chen, Xu-Tao, et al.
Publicado: (2019)

Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy
por: Nakano, Yujiro, et al.
Publicado: (2018)

In Reply to “Abdominal Pressure and Fluid Status After Kidney Transplantation”
por: Dupont, Vincent, et al.
Publicado: (2022)

Could Salivary Cyclosporine Dosage Replace the Whole Blood Cyclosporine Measurements in Renal Transplant Patients?
por: Aboujaoude, Samia, et al.
Publicado: (2017)

Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Based Immunosuppression
por: Yousif, Elamein, et al.
Publicado: (2022)

Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012)

Possible dose-dependent effect of eplerenone on intraocular pressure
por: Razavi, Seyedeh Mehrsa Sadat, et al.
Publicado: (2023)

Analyses of AUC((0–12)) and C(0) Compliances within Therapeutic Ranges in Kidney Recipients Receiving Cyclosporine or Tacrolimus
por: Radzevičienė, Aurelija, et al.
Publicado: (2020)

Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients
por: Kaxiras, Anastasios, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7ma3oqmlt6h2jgc6dcc14peeo5